Grant: Idea to Innovation
University of Waterloo
$15,000.00
Enzyme Degradable Gelatin Hydrogel for Payload Delivery in Wound Healing
FY 2023-24
Summary
An ideal drug delivery system would be able to deliver a payload to a specific site consistently over time through a controlled release trigger. This is particularly important in the case of wound care, where a steady release of a therapeutic over time leads to better outcomes, especially for chronic, non-healing wounds. Gelatin methacrylate (GelMA) hydrogels are often employed for drug delivery due to their biocompatibility and the ability to absorb and release soluble compounds; however, their drawback is that unmodified GelMA possesses poor mechanical strength and high porosity, leading to an extremely rapid and uncontrolled release rate. The present invention provides a method of fabricating a GelMA hydrogel, named GelMA+, having improved mechanical strength, payload encapsulation, and favourable biodegradation kinetics when exposed to matrix metalloproteinases (MMPs), which are enzymes that are significantly upregulated during wound healing. By incorporating a payload into the newly developed GelMA+ hydrogel, which is subsequently triggered to degrade when in contact with MMPs, a new delivery system for wound healing has been realized.As part of this Market Assessment grant, the selected consultant (Optimal Innovation Group - OIG) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
586928-2023
Name nom
Yim, Evelyn KFE
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
9100
Research subject group en
Recherche biomédicale
Research subject group fr
Medical sciences
Research subject en
Biomedical
Research subject fr
Sciences médicales
Application title
Enzyme Degradable Gelatin Hydrogel for Payload Delivery in Wound Healing
Keyword
Biomaterials; commercialization; consultant; Controlled release; enzyme degradable hydrogel; Enzyme triggered release; Gelatin methacrylate; hydrogel; matrix metalloproteinases; Wound healing
Application summary
An ideal drug delivery system would be able to deliver a payload to a specific site consistently over time through a controlled release trigger. This is particularly important in the case of wound care, where a steady release of a therapeutic over time leads to better outcomes, especially for chronic, non-healing wounds. Gelatin methacrylate (GelMA) hydrogels are often employed for drug delivery due to their biocompatibility and the ability to absorb and release soluble compounds; however, their drawback is that unmodified GelMA possesses poor mechanical strength and high porosity, leading to an extremely rapid and uncontrolled release rate. The present invention provides a method of fabricating a GelMA hydrogel, named GelMA+, having improved mechanical strength, payload encapsulation, and favourable biodegradation kinetics when exposed to matrix metalloproteinases (MMPs), which are enzymes that are significantly upregulated during wound healing. By incorporating a payload into the newly developed GelMA+ hydrogel, which is subsequently triggered to degrade when in contact with MMPs, a new delivery system for wound healing has been realized.As part of this Market Assessment grant, the selected consultant (Optimal Innovation Group - OIG) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.